Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating a vaccine therapy in combination with trastuzumab for patients with Stage IV HER2-positive breast cancer or ovarian cancer who are …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)
• Vaccine therapy

Snippet

Sponsor: University of Washington | Conditions: HER2/Neu Positive, HLA-A2 Positive Cells Present | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-06-21